Knut Ringbom appointed CEO of Biovian
Dr. Knut Ringbom (46) has effective 1. January 2013 been appointed Chief Executive Officer (CEO) at Biovian.Ringbom will move to the CEO position from his current position as Director of Business Development and Projects at Biovian. Ringbom is one of the co-founders of Biovian. Ringbom has earlier held project- and sales management positions at BioTie Therapies Corp, Perkin Elmer Wallac and Metso Corp.
Biovian’s former CEO Mr. Sakari Heyno will continue in Biovian’s business development and as member of the board.
Jari Saarinen, Chairman of the board
+358 40 500 4206
Knut Ringbom, CEO
+358 40 517 1217
Biovian is a one-stop-shop CMO for cGMP manufacture and development of biopharmaceuticals. Biovian offers cell line development, mammalian cultivation, microbial fermentation, protein purification, viral vector production, formulation, aseptic filling, labeling and QP release. Biovian's 2300 m2 facilities are EMA and FDA certified for cGMP manufacture of investigational and commercial products.